Transcription factors TP63 facilitates malignant progression of thyroid cancer by upregulating KRT17 expression and inducing epithelial-mesenchymal transition

References

• Chiang, Chang-Hsu, Chih-Ching Wu, Li-Yu Lee, Yi-Chen Li, Hao-Ping Liu, Chia-Wei Hsu, Ya-Ching Lu, et al. 2016. “Proteomics Analysis Reveals Involvement of Krt17 in Areca Nut-Induced Oral Carcinogenesis.” Journal of Proteome Research 15 (9): 2981–2997. doi:10.1021/acs.jproteome.6b00138.
   PubMed Web of Science ®Google Scholar
• Chivu-Economescu, Mihaela, Denisa L. Dragu, Laura G. Necula, Lilia Matei, Ana Maria Enciu, Coralia Bleotu, Carmen C. Diaconu, et al. 2017. “Knockdown of KRT17 by siRNA Induces Antitumoral Effects on Gastric Cancer Cells.” Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20 (6): 948–959. doi:10.1007/s10120-017-0712-y.
   PubMed Web of Science ®Google Scholar
• Graziano, V., and V. De Laurenzi. 2011. “Role of p63 in Cancer Development.” Biochimica et Biophysica Acta 1816 (1): 57–66. doi:10.1016/j.bbcan.2011.04.002.
   PubMed Web of Science ®Google Scholar
• Hao, Ru-Tian, Chen Zheng, Chen-Yong Wu, Er-Jie Xia, Xiao-Fen Zhou, Rui-Da Quan, Xiao-Hua Zhang, et al. 2019. “NECTIN4 Promotes Papillary Thyroid Cancer Cell Proliferation, Migration, and Invasion and Triggers EMT by Activating AKT.” Cancer Management and Research 11: 2565–2578. doi:10.2147/cmar.S190332.
   PubMed Web of Science ®Google Scholar
• Herrmann, H., and U. Aebi. 2004. “Intermediate Filaments: Molecular Structure, Assembly Mechanism, and Integration into Functionally Distinct Intracellular Scaffolds.” Annual Review of Biochemistry 73: 749–789. doi:10.1146/annurev.biochem.73.011303.073823.
   PubMed Web of Science ®Google Scholar
• Hobbs, R. P., A. S. Batazzi, M. C. Han, and P. A. Coulombe. 2016. “Loss of Keratin 17 Induces Tissue-Specific Cytokine Polarization and Cellular Differentiation in HPV16-Driven Cervical Tumorigenesis in Vivo.” Oncogene 35 (43): 5653–5662. doi:10.1038/onc.2016.102.
   PubMed Web of Science ®Google Scholar
• Huilgol, D., P. Venkataramani, S. Nandi, and S. Bhattacharjee. 2019. “Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer.” Genes 10(10):794. doi:10.3390/genes10100794.
   PubMed Web of Science ®Google Scholar
• Jiang, Yuan, Yan-Yi Jiang, Jian-Jun Xie, Anand Mayakonda, Masaharu Hazawa, Li Chen, Jin-Fen Xiao, et al. 2018. “Co-Activation of Super-Enhancer-Driven CCAT1 by TP63 and SOX2 Promotes Squamous Cancer Progression.” Nature Communications 9 (1): 3619. doi:10.1038/s41467-018-06081-9.
   PubMedGoogle Scholar
• Kajiwara, Chihiro, Katsumi Fumoto, Hirokazu Kimura, Satoshi Nojima, Keita Asano, Kazuki Odagiri, Makoto Yamasaki, et al. 2018. “p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4.” Cancer Research 78 (21): 6107–6120. doi:10.1158/0008-5472.CAN-18-1749.
   PubMed Web of Science ®Google Scholar
• Khanom, Rumana, Chi Thi Kim Nguyen, Kou Kayamori, Xin Zhao, Keiichi Morita, Yoshio Miki, Ken-Ichi Katsube, et al. 2016. “Keratin 17 is Induced in Oral Cancer and Facilitates Tumor Growth.” PLoS One 11 (8): e0161163. doi:10.1371/journal.pone.0161163.
   PubMed Web of Science ®Google Scholar
• Kim, Chan Yong, Woon Yong Jung, Hyun Joo Lee, Han Kyeom Kim, Aeree Kim, and Bong Kyung Shin. 2012. “Proteomic Analysis Reveals Overexpression of Moesin and Cytokeratin 17 Proteins in Colorectal Carcinoma.” Oncology Reports 27 (3): 608–620. doi:10.3892/or.2011.1545.
   PubMed Web of Science ®Google Scholar
• Kim, S., P. Wong, and P. A. Coulombe. 2006. “A Keratin Cytoskeletal Protein Regulates Protein Synthesis and Epithelial Cell Growth.” Nature 441 (7091): 362–365. doi:10.1038/nature04659.
   PubMed Web of Science ®Google Scholar
• Lambert, M., S. Jambon, S. Depauw, and M. H. David-Cordonnier. 2018. “Targeting Transcription Factors for Cancer Treatment.” Molecules 23(6):1479. doi:10.3390/molecules23061479.
   PubMed Web of Science ®Google Scholar
• Larue, L., and A. Bellacosa. 2005. “Epithelial-Mesenchymal Transition in Development and Cancer: Role of Phosphatidylinositol 3' Kinase/AKT Pathways.” Oncogene 24 (50): 7443–7454. doi:10.1038/sj.onc.1209091.
   PubMed Web of Science ®Google Scholar
• Leboulleux, Sophie, Carole Rubino, Eric Baudin, Bernard Caillou, Dana M. Hartl, Jean-Michel Bidart, Jean-Paul Travagli, et al. 2005. “Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis.” The Journal of Clinical Endocrinology and Metabolism 90 (10): 5723–5729. doi:10.1210/jc.2005-0285.
   PubMed Web of Science ®Google Scholar
• Li, Ding, Xiao-Feng Ni, Hengjie Tang, Jiecheng Zhang, Chenlei Zheng, Jianhu Lin, Cheng Wang, et al. 2020. “KRT17 Functions as a Tumor Promoter and Regulates Proliferation, Migration and Invasion in Pancreatic Cancer via mTOR/S6k1 Pathway.” Cancer Management and Research 12: 2087–2095. doi:10.2147/CMAR.S243129.
   PubMed Web of Science ®Google Scholar
• Liu, Zhun, Shaobin Yu, Shuting Ye, Zhimin Shen, Lei Gao, Ziyang Han, Peipei Zhang, et al. 2020. “Keratin 17 Activates AKT Signalling and Induces Epithelial-Mesenchymal Transition in Oesophageal Squamous Cell Carcinoma.” Journal of Proteomics 211: 103557. doi:10.1016/j.jprot.2019.103557.
   PubMed Web of Science ®Google Scholar
• Lu, Y., et al. 2021. “Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma.” OncoTargets and Therapy 14: 711–723. doi:10.2147/OTT.S279287.
   PubMed Web of Science ®Google Scholar
• Malaguarnera, Roberta, Angelo Mandarino, Emanuela Mazzon, Veronica Vella, Piero Gangemi, Carlo Vancheri, Paolo Vigneri, et al. 2005. “The p53-Homologue p63 May Promote Thyroid Cancer Progression.” Endocrine-Related Cancer 12 (4): 953–971. doi:10.1677/erc.1.00968.
   PubMed Web of Science ®Google Scholar
• Okegawa, T., R. C. Pong, Y. Li, and J. T. Hsieh. 2004. “The Role of Cell Adhesion Molecule in Cancer Progression and Its Application in Cancer Therapy.” Acta Biochimica Polonica 51 (2): 445–457.
   PubMed Web of Science ®Google Scholar
• Papavassiliou, K. A., and A. G. Papavassiliou. 2016. “Transcription Factor Drug Targets.” Journal of Cellular Biochemistry 117 (12): 2693–2696. doi:10.1002/jcb.25605.
   PubMed Web of Science ®Google Scholar
• Pozniak, C. D., S. Radinovic, A. Yang, F. McKeon, D. R. Kaplan, and F. D. Miller. 2000. “An Anti-Apoptotic Role for the p53 Family Member, p73, during Developmental Neuron Death.” Science 289 (5477): 304–306. doi:10.1126/science.289.5477.304.
   PubMed Web of Science ®Google Scholar
• Revathidevi, S., and A. K. Munirajan. 2019. “Akt in Cancer: Mediator and More.” Seminars in Cancer Biology 59: 80–91. doi:10.1016/j.semcancer.2019.06.002.
   PubMed Web of Science ®Google Scholar
• Rickman, D. S., R. Millon, A. De Reynies, E. Thomas, C. Wasylyk, D. Muller, J. Abecassis, et al. 2008. “Prediction of Future Metastasis and Molecular Characterization of Head and Neck Squamous-Cell Carcinoma Based on Transcriptome and Genome Analysis by Microarrays.” Oncogene 27 (51): 6607–6622. doi:10.1038/onc.2008.251.
   PubMed Web of Science ®Google Scholar
• Sankar, Savita, Jason M. Tanner, Russell Bell, Aashi Chaturvedi, R. Lor Randall, Mary C. Beckerle, Stephen L. Lessnick, et al. 2013. “A Novel Role for Keratin 17 in Coordinating Oncogenic Transformation and Cellular Adhesion in Ewing Sarcoma.” Molecular and Cellular Biology 33 (22): 4448–4460. doi:10.1128/MCB.00241-13.
   PubMed Web of Science ®Google Scholar
• Schneider, D. F., and H. Chen. 2013. “New Developments in the Diagnosis and Treatment of Thyroid Cancer.” CA: A Cancer Journal for Clinicians 63 (6): 374–394. doi:10.3322/caac.21195.
   PubMed Web of Science ®Google Scholar
• Shariati, M., and F. Meric-Bernstam. 2019. “Targeting AKT for Cancer Therapy.” Expert Opinion on Investigational Drugs 28 (11): 977–988. doi:10.1080/13543784.2019.1676726.
   PubMed Web of Science ®Google Scholar
• Shi, Y., P. Ye, and X. Long. 2017. “Differential Expression Profiles of the Transcriptome in Breast Cancer Cell Lines Revealed by Next Generation Sequencing.” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 44 (2): 804–816. doi:10.1159/000485344.
   PubMedGoogle Scholar
• Sundqvist, Anders, Eleftheria Vasilaki, Oleksandr Voytyuk, Yu Bai, Masato Morikawa, Aristidis Moustakas, Kohei Miyazono, et al. 2020. “TGFbeta and EGF Signaling Orchestrates the AP-1- and p63 Transcriptional Regulation of Breast Cancer Invasiveness.” Oncogene 39 (22): 4436–4449. doi:10.1038/s41388-020-1299-z.
   PubMed Web of Science ®Google Scholar
• Wang, Zhao, Mai-Qing Yang, Lei Lei, Liang-Ru Fei, Yi-Wen Zheng, Wen-Jing Huang, Zhi-Han Li, et al. 2019. “Overexpression of KRT17 Promotes Proliferation and Invasion of Non-Small Cell Lung Cancer and Indicates Poor Prognosis.” Cancer Management and Research 11: 7485–7497. doi:10.2147/CMAR.S218926.
   PubMed Web of Science ®Google Scholar
• Westfall, M. D., and J. A. Pietenpol. 2004. “p63: Molecular Complexity in Development and Cancer.” Carcinogenesis 25 (6): 857–864. doi:10.1093/carcin/bgh148.
   PubMed Web of Science ®Google Scholar
• Xie, Jian-Jun, Yan-Yi Jiang, Yuan Jiang, Chun-Quan Li, Mei-Chee Lim, Omer An, Anand Mayakonda, et al. 2018. “Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.” Gastroenterology 154 (8): 2137 e2131–2151 e2131. doi:10.1053/j.gastro.2018.02.018.
   PubMed Web of Science ®Google Scholar
• Yan, Wei., Yu Fu, Dean Tian, Jiazhi Liao, Mei Liu, Bo Wang, Limin Xia, et al. 2009. “PI3 Kinase/Akt Signaling Mediates Epithelial-Mesenchymal Transition in Hypoxic Hepatocellular Carcinoma Cells.” Biochemical and Biophysical Research Communications 382 (3): 631–636. doi:10.1016/j.bbrc.2009.03.088.
   PubMed Web of Science ®Google Scholar
• Yan, Xianke, Chao Yang, Wei Hu, Tao Chen, Qi Wang, Feng Pan, Bing Qiu, et al. 2020. “Knockdown of KRT17 Decreases Osteosarcoma Cell Proliferation and the Warburg Effect via the AKT/mTOR/HIF1alpha Pathway.” Oncology Reports 44 (1): 103–114. doi:10.3892/or.2020.7611.
   PubMed Web of Science ®Google Scholar
• Zaballos, M. A., and P. Santisteban. 2017. “Key Signaling Pathways in Thyroid Cancer.” The Journal of Endocrinology 235 (2): R43–R61. doi:10.1530/JOE-17-0266.
   PubMed Web of Science ®Google Scholar
• Zhang, X., M. Yin, and L. J. Zhang. 2019. “Keratin 6, 16 and 17-Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis.” Cells 8(8):807. doi:10.3390/cells8080807.
   Web of Science ®Google Scholar
• Zhao, Xin-Ge, Jing-Ye Hu, Jun Tang, Wei Yi, Mei-Yin Zhang, Rong Deng, Shi-Juan Mai, et al. 2019. “miR-665 Expression Predicts Poor Survival and Promotes Tumor Metastasis by Targeting NR4A3 in Breast Cancer.” Cell Death & Disease 10 (7): 479. doi:10.1038/s41419-019-1705-z.
   PubMedGoogle Scholar